The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Tissue Heart Valves Market Between 2026 And 2030?
The tissue heart valves market size has experienced consistent expansion in recent years. This market is set to increase from $1.52 billion in 2025 to $1.56 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 2.6%. Historically, its growth can be linked to several factors, including growth in cardiovascular diseases, limitations of mechanical valves, surgical valve replacement adoption, hospital cardiac infrastructure, and aging demographics.
The tissue heart valves market is projected for consistent expansion in the coming years, anticipated to reach $1.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 2.5%. Factors contributing to this growth during the forecast period include the increasing adoption of TAVR procedures, the rise in minimally invasive cardiac surgeries, innovations leading to greater valve durability, improved healthcare accessibility, and the expansion of cardiology specialization. Key trends expected over the forecast period encompass a shift towards bioprosthetic valves, the growing number of transcatheter valve procedures, advancements in tissue preservation methods, a decrease in the need for long-term anticoagulation, and the increasing demand for valve replacement driven by an aging population.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/tissue-heart-valves-global-market-report
What Key Factors Are Affecting The Tissue Heart Valves Market Demand?
The expanding occurrence of cardiovascular diseases is projected to drive the future expansion of the tissue heart valves market. Cardiovascular diseases (CVDs) encompass a category of ailments impacting the heart and blood vessels, featuring conditions like heart attacks, strokes, and high blood pressure. The rising incidence of cardiovascular diseases (CVDs) is largely fueled by elements such as unhealthy living habits, an aging demographic, a greater presence of risk factors, inadequate diets, sedentary behavior, tobacco use, stress, and urban development, resulting in elevated worldwide rates of heart-related conditions. Tissue heart valves play a vital role in managing cardiovascular diseases (CVDs), offering a biocompatible, long-lasting, and less clot-forming option for individuals needing valve replacement, thereby enhancing long-term cardiac performance and mitigating complication risks. As an illustration, in September 2024, a report released by the Heart Failure Society of America (HFSA), a US-based professional organization company, stated that roughly 6.7 million Americans aged 20 and older are currently suffering from heart failure (HF), with forecasts suggesting this figure will rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050 respectively. Consequently, the growing frequency of cardiovascular diseases stimulates the expansion of the tissue heart valve market.
Which Segment Categories Are Included In The Tissue Heart Valves Market Segment Analysis?
The tissue heart valves market covered in this report is segmented –
1) By Type: Stented Tissue Heart Valves, Stentless Tissue Heart Valves
2) By Procedure Type: Surgical Aortic Valve Replacement (SAVR), Transcatheter Aortic Valve Replacement (TAVR)
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Stented Tissue Heart Valves: Bovine Pericardial Valves, Porcine Valves
2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves, Homograft Valves
What Trends Are Influencing Changes In The Tissue Heart Valves Market?
Leading companies in the tissue heart valves market are concentrating on developing innovative products, such as surgical aortic tissue valves, to simplify implantation and lifelong patient management. A surgical aortic tissue valve is a prosthetic heart valve made from biological tissue, typically utilized to replace a diseased or damaged aortic valve in heart surgery. For instance, in June 2024, Medtronic plc., an Ireland-based technology company, launched the Avalus Ultra valve, a next-generation surgical aortic tissue valve designed to enhance ease of use during implantation and support long-term patient management. Built upon 10 years of clinical experience with the Avalus valve, it features a low valve profile, a polyetheretherketone (PEEK) base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA) for improved blood flow. The valve also includes a radiopaque coil for clear visibility in future valve-in-valve procedures, offering long-term durability for patients with aortic stenosis.
Who Are The Active Companies Shaping The Tissue Heart Valves Market?
Major companies operating in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomédica, Anteris Technologies Ltd., Labcor Laboratórios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, St. Jude Medical Inc., Sorin Group, Hancock J & Co.
Get The Full Tissue Heart Valves Market Report:
https://www.thebusinessresearchcompany.com/report/tissue-heart-valves-global-market-report
Which Geographic Region Dominates The Tissue Heart Valves Market?
North America was the largest region in the tissue heart valves market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue heart valves market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Tissue Heart Valves Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/tissue-heart-valves-global-market-report
Browse Through More Reports Similar to the Global Tissue Heart Valves Market 2026, By The Business Research Company
Prosthetic Heart Valve Devices And Equipment Market Report 2026
Pediatric Heart Valve Repair And Replacement Market Report 2026
Commercial Valves Market Report 2026
https://www.thebusinessresearchcompany.com/report/commercial-valves-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model